Project Description:
The ADHD translational research program, directed by CEDD faculty Julie Schweitzer, Ph.D., undertakes research activities in etiology, assessment, treatment, and outcomes, using neuroscience and behavioral methods. It offers both neuroscience research activities in ADHD and evidence based training and treatment models for ADHD throughout the lifespan. Over the next five years translational research activities in ADHD will expand to: 1) better understand the neural and behavioral trajectory of ADHD and associated impairments during adolescence and emerging adulthood. 2) identify compensatory functional behavioral and neural activity in ADHD and explore ways that this compensatory behavior (e.g., fidgeting) might lead to novel treatments. 3) conduct novel studies in ADHD subtypes (presentations) and the implications these subgroups of ADHD have for treatment implications. 4) focus on how technology (e.g., virtual reality therapy) can support improved attention and self-control in ADHD. 5) investigate the presence and treatment of attentional symptoms in other neurodevelopmental disorders (e.g., fragile X, ASD). 6) develop communication and dissemination projects for ADHD that help stakeholders identify resources for treating ADHD and related challenges and teach stakeholders how to evaluate the legitimacy of information on the internet and other sources regarding ADHD.
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities, Quality of Life, Other - Leadership
Target Audience:
Students/Trainees (long or intermediate trainees), Community Trainees / Short term trainees, Professionals and Para-Professionals, Family Members/Caregivers, Adults with Disabilities, Children/Adolescents with Disabilities/SHCN, Legislators/Policy Makers, General Public
Unserved or Under-served Populations:
Specific Groups
Primary Target Audience Geographic Descriptor:
State, National, International
COVID-19 Related Data:
N/A
